Replies to post #343 on Rockwell Medical Technologies, Inc. (RMTI)

[DorseyE]

From the PR.......
About Triferic

Triferic is the only FDA-approved therapy in the U.S. indicated to replace iron and maintain hemoglobin in hemodialysis patients during each dialysis treatment. Triferic has a unique and differentiated mechanism of action which has the potential to benefit patients and health care economics. Triferic represents a potential innovative medical advancement in hemodialysis patient iron management– with the potential to become the future standard of care.[/The Company has two FDA-approved formulations of Triferic (1) Triferic Dialysate and (2) Triferic AVNU.

[DorseyE]

Rockwell’s analyst coverage has been very favorable:

IFS SECURITIES – STRONG BUY
PIPER SANDLER – STRONG BUY
H C Wainwright – STRONG BUY
The potential for upside if the drug is approved this week could be massive.

I think you are right investor//// after the weekend maybe some will wake up!!!